Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma	Advanced Hepatocellular Carcinoma (HCC)	Recruiting	Phase 1 / Phase 2	2025-08-14		NCT07123545

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hangzhou Neoantigen Therapeutics Co., Ltd.	11
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	29

Clinical trials